ATE240097T1 - Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten - Google Patents

Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten

Info

Publication number: ATE240097T1
Authority: AT; Austria
Prior art keywords: ephedrine; pharmaceutical composition; composition containing; receptor antagonist; substantially free
Prior art date: 1997-11-14

Application number

AT98956561T

Other languages

English (en)

Inventor

Anthony R Booth

William T Sherman

Peter Raven

James L Caffrey

Thomas Yorio

Michael Forster

Patricia Gwirtz

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-14

Filing date

1998-11-04

Publication date

2003-05-15

1998-11-04 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE240097T1 publication Critical patent/ATE240097T1/de

Links

KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title abstract 6
KWGRBVOPPLSCSI-PSASIEDQSA-N (1s,2r)-2-(methylamino)-1-phenylpropan-1-ol Chemical compound CN[C@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-PSASIEDQSA-N 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 3
239000000938 histamine H1 antagonist Substances 0.000 title 1
KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000000150 Sympathomimetic Substances 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
239000002830 appetite depressant Substances 0.000 abstract 1
239000000850 decongestant Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940127230 sympathomimetic drug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Pulmonology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT98956561T 1997-11-14 1998-11-04 Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten ATE240097T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6557297P	1997-11-14	1997-11-14
PCT/US1998/023479 WO1999025328A1 (en)	1997-11-14	1998-11-04	(+)-ephedrine as a sympathomimetic drug

Publications (1)

Publication Number	Publication Date
ATE240097T1 true ATE240097T1 (de)	2003-05-15

Family

ID=22063647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98956561T ATE240097T1 (de)	1997-11-14	1998-11-04	Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten

Country Status (8)

Country	Link
EP (1)	EP1030659B1 (de)
AT (1)	ATE240097T1 (de)
AU (1)	AU1305999A (de)
DE (1)	DE69814669T2 (de)
DK (1)	DK1030659T3 (de)
ES (1)	ES2199474T3 (de)
PT (1)	PT1030659E (de)
WO (1)	WO1999025328A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1314199B1 (it) *	1999-10-20	2002-12-06	Ambros Pharma S R L	Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
DE10148233A1 (de) *	2001-09-28	2003-04-10	Boehringer Ingelheim Pharma	Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme

1998
- 1998-11-04 PT PT98956561T patent/PT1030659E/pt unknown
- 1998-11-04 AT AT98956561T patent/ATE240097T1/de not_active IP Right Cessation
- 1998-11-04 DK DK98956561T patent/DK1030659T3/da active
- 1998-11-04 EP EP98956561A patent/EP1030659B1/de not_active Expired - Lifetime
- 1998-11-04 AU AU13059/99A patent/AU1305999A/en not_active Abandoned
- 1998-11-04 DE DE69814669T patent/DE69814669T2/de not_active Expired - Fee Related
- 1998-11-04 ES ES98956561T patent/ES2199474T3/es not_active Expired - Lifetime
- 1998-11-04 WO PCT/US1998/023479 patent/WO1999025328A1/en not_active Ceased

Also Published As

Publication number	Publication date
AU1305999A (en)	1999-06-07
EP1030659B1 (de)	2003-05-14
WO1999025328A1 (en)	1999-05-27
DE69814669D1 (de)	2003-06-18
DK1030659T3 (da)	2003-09-15
PT1030659E (pt)	2003-09-30
ES2199474T3 (es)	2004-02-16
EP1030659A1 (de)	2000-08-30
DE69814669T2 (de)	2003-11-27

Similar Documents

Publication	Publication Date	Title
AU692042B2 (en)	1998-05-28	Transdermal system for the simultaneous delivery of a number of active principles
GEP20022784B (en)	2002-09-25	Celecoxib Composition
IS4146A (is)	1994-10-31	Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
GR1002097B (en)	1995-12-28	A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
NO993520D0 (no)	1999-07-16	Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
MY118371A (en)	2004-10-30	Tetrahydrolipstatin containing compositions
GEP20002013B (en)	2000-04-10	Therapeutical Means
CA2260943A1 (en)	1998-02-19	Formulation of 5-ht agonists
NZ319531A (en)	1999-11-29	An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
GEP20033131B (en)	2003-12-25	Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
IL76932A (en)	1989-07-31	Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
MXPA02007690A (es)	2004-08-23	Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide.
BR0012080A (pt)	2002-05-07	Métodos e composições para administração intranasal de apomorfina
BR9510168A (pt)	1997-10-14	Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
BG102668A (en)	1999-04-30	Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
FR2735369B1 (fr)	1997-07-11	Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
EP0663835A1 (de)	1995-07-26	Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft.
ES2189252T3 (es)	2003-07-01	Composiciones analgesicas que comprenden un antagonista de la colecistoquinina y un opioide.
UA50721C2 (uk)	2002-11-15	Композиція з подовженою дією, що містить цизаприд-(l)-тартрат
BG105570A (en)	2002-02-28	Pharmaceutical compositions for modified release insulin sensitiser
PL348202A1 (en)	2002-05-06	Pharmaceutically active composition and dispensing device
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
AP2001002084A0 (en)	2001-03-31	Orally administered controlled delivery system for once daily adminstration of ciprofloxacin
DE69814669D1 (de)	2003-06-18	Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
AU8019898A (en)	1998-12-08	Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome

Legal Events

Date

Code

Title

Description

2004-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1030659

Country of ref document: EP

2006-08-15

REN

Ceased due to non-payment of the annual fee